9.13BINR
Type
Common Stock
Exchange
NSE
Currency Code
INR
Currency Name
Indian Rupee
Country Name
India
Country ISO
IN
ISIN
INE010B01027
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
March
IPO date
-
Updated At
-
PE Ratio
17.60
PEG Ratio
-
Book Value
251.49
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
49.09
Wall Street Target Price
992.07
EPS Estimate Current Year
45.05
EPS Estimate Next Year
41.53
EPS Estimate Current Quarter
10.8452
EPS Estimate Next Quarter
7.3579
Most Recent Quarter
-
Revenue TTM
260,892,999,680
Gross Profit TTM
188,755,001,344
EBITDA
72,775,753,728
Profit Margin
18.93%
Return On Assets TTM
9.54%
Return On Equity TTM
19.25%
Revenue Per Share TTM
259.258
Qtly Revenue Growth YOY
30.30%
Diluted Eps TTM
49.09
Qtly Earnings Growth YOY
1.90%
Trailing PE
17.60
Forward PE
14
Price Sales TTM
3.3334
Price Book MRQ
3.437
Enterprise Value Revenue
3
Enterprise Value EBITDA
11
6756.40
3.68%6753.00
3.56%4472.90
1.42%4472.95
1.38%2263.40
0.48%2264.20
0.43%1376.50
-0.82%1268.50
-0.56%1779.40
-0.51%1446.15
-0.39%